Evidence map›Paper›PMID 32694525›Full record

ArticleNature communications2020

A global lipid map defines a network essential for Zika virus replication.

Hans C Leier, Jules B Weinstein, Jennifer E Kyle, Joon-Yong Lee, Lisa M Bramer, Kelly G Stratton, Douglas Kempthorne, Aaron R Navratil, Endale G Tafesse, Thorsten Hornemann and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 94 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Lipid Architecture in the Zika Virus.ACS physical chemistry Au · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Measles virus reprograms CD4Frontiers in cell and developmental biology · 2026
    Article
  18. Review
  19. The inhibition mechanism ofFrontiers in microbiology · 2026
    Review
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Hans C LeierDepartment of Molecular Microbiology & Immunology, Oregon Health & Science University (OHSU), Portland, OR, 97239, USA.ORCID http://orcid.org/0000-0002-0363-1444
Jules B WeinsteinDepartment of Molecular Microbiology & Immunology, Oregon Health & Science University (OHSU), Portland, OR, 97239, USA.ORCID http://orcid.org/0000-0002-2983-3386
Jennifer E KyleBiological Sciences Division, Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory (PNNL), Richland, WA, 99352, USA.
Joon-Yong LeeBiological Sciences Division, Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory (PNNL), Richland, WA, 99352, USA.ORCID http://orcid.org/0000-0002-5864-8518
Lisa M BramerComputing and Analytics Division, National Security Directorate, PNNL, Richland, WA, 99352, USA.ORCID http://orcid.org/0000-0002-8384-1926
Kelly G StrattonComputing and Analytics Division, National Security Directorate, PNNL, Richland, WA, 99352, USA.
Douglas KempthorneDepartment of Molecular Microbiology & Immunology, Oregon Health & Science University (OHSU), Portland, OR, 97239, USA.
Aaron R NavratilDepartments of Chemistry & Biochemistry and Pharmacology, University of California San Diego School of Medicine, La Jolla, CA, 92093, USA.
Endale G TafesseDepartment of Plant Sciences, College of Agriculture and Bioresources, University of Saskatchewan, Saskatoon, SK, S7N 5A8, Canada.
Thorsten HornemannUniversity Zurich and University Hospital Zurich, University of Zurich, Zurich, 8091, Switzerland.ORCID http://orcid.org/0000-0002-4218-1087
William B MesserDepartment of Molecular Microbiology & Immunology, Oregon Health & Science University (OHSU), Portland, OR, 97239, USA.
Edward A DennisDepartments of Chemistry & Biochemistry and Pharmacology, University of California San Diego School of Medicine, La Jolla, CA, 92093, USA.ORCID http://orcid.org/0000-0003-3738-3140
Thomas O MetzBiological Sciences Division, Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory (PNNL), Richland, WA, 99352, USA.ORCID http://orcid.org/0000-0001-6049-3968
Eric BarklisDepartment of Molecular Microbiology & Immunology, Oregon Health & Science University (OHSU), Portland, OR, 97239, USA.
Fikadu G TafesseDepartment of Molecular Microbiology & Immunology, Oregon Health & Science University (OHSU), Portland, OR, 97239, USA. tafesse@ohsu.edu.ORCID http://orcid.org/0000-0002-8575-4164
Oregon Health & Science University · USPacific Northwest National Laboratory · USUniversity of California San Diego · USUniversity of Saskatchewan · CAUniversity of Zurich · CH

Funding

STEROL LIPIDSU54GM069338 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DENNIS, EDWARD A · 2003 to 2013
$72.2M
Oregon Clinical and Translational Research InstituteUL1TR000128 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ELLISON, DAVID H · 2012 to 2015
$28.7M
Systems Biology Identifies Restriction Factors for West Nile VirusU19AI106772 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI WATERS, KATRINA M. · 2013 to 2017
$26.1M
Virus CoreU19AI106754 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BENNER, CHRISTOPHER W · 2013 to 2017
$26.0M
In Vitro Analysis of HIV Gag Protein InteractionsR01GM060170 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI BARKLIS, ERIC W · 1999 to 2019
$5.9M
LIPIDOMICS BASED DIAGNOSTICS FOR NONALCOHOLIC STEATOHEPATITISR01DK105961 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI DENNIS, EDWARD A, SANYAL, ARUN J · 2015 to 2018
$2.8M
HIV-1 Gag Precursor Protein InteractionsR01AI152579 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI BARKLIS, ERIC W · 2020 to 2024
$2.5M
Determining the role of sphingolipids in Mycobacterium tuberculosis infectionR01AI141549 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI TAFESSE, FIKADU G. · 2020 to 2025
$2.4M
Dengue virus immunity in endemic and non-endemic human cohortsR21AI135537 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI MESSER, WILLIAM · 2018 to 2019
$439k
Determining the role of host lipids in Zika virus infectionR21AI133631 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI TAFESSE, FIKADU G. · 2017 to 2018
$424k
NCATS NIH HHS UL1 TR000128NIAID NIH HHS R01 AI141549NIAID NIH HHS R01 AI152579NIAID NIH HHS R21 AI133631NIAID NIH HHS R21 AI135537NIAID NIH HHS U19 AI106754NIAID NIH HHS U19 AI106772NIDDK NIH HHS R01 DK105961NIGMS NIH HHS R01 GM060170NIGMS NIH HHS U54 GM069338
6 · The paper itself

Abstract

Zika virus (ZIKV), an arbovirus of global concern, remodels intracellular membranes to form replication sites. How ZIKV dysregulates lipid networks to allow this, and consequences for disease, is poorly understood. Here, we perform comprehensive lipidomics to create a lipid network map during ZIKV infection. We find that ZIKV significantly alters host lipid composition, with the most striking changes seen within subclasses of sphingolipids. Ectopic expression of ZIKV NS4B protein results in similar changes, demonstrating a role for NS4B in modulating sphingolipid pathways. Disruption of sphingolipid biosynthesis in various cell types, including human neural progenitor cells, blocks ZIKV infection. Additionally, the sphingolipid ceramide redistributes to ZIKV replication sites, and increasing ceramide levels by multiple pathways sensitizes cells to ZIKV infection. Thus, we identify a sphingolipid metabolic network with a critical role in ZIKV replication and show that ceramide flux is a key mediator of ZIKV infection.

Indexed as

Host-Pathogen InteractionsAnimalsCell Line, TumorChlorocebus aethiopsHEK293 CellsHumansLipidomicsMiceSphingolipidsVero CellsViral Nonstructural ProteinsVirus ReplicationZika VirusZika Virus InfectionSphingolipidsViral Nonstructural Proteins

Identifiers

PMID32694525
PMCPMC7374707
OpenAlexW3045281535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.